SAN RAMON, Calif., Feb. 18, 2020 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE:COO), will participate in the Oppenheimer 30th Annual Healthcare Conference in New York City, NY, on March 17, 2020. Daniel McBride, Esq, Executive Vice President, Chief Operating Officer & President of CooperVision, will represent the Company in a session scheduled to begin at 1:00PM ET. A webcast of the session will be available on the Investor Relations section of the Company's website at http://investor.coopercos.com.
About CooperCompanies
CooperCompanies ("Cooper") is a global medical device company publicly traded on the NYSE (NYSE:COO). Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to developing a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical is committed to advancing the health of women, babies and families with its diversified portfolio of products and services focusing on medical devices and fertility & genomics. Headquartered in San Ramon, Calif., Cooper has a workforce of more than 12,000 with products sold in over 100 countries. For more information, please visit www.coopercos.com.
Contact:
Kim Duncan
Vice President, Investor Relations and Risk Management
925-460-3663
ir@cooperco.com